TY  - GEN
AU  - Xu,Xiaoyue
AU  - Yu,Shaorong
AU  - Sun,Wenbo
AU  - Qin,Xiaobing
AU  - Chen,Yan
AU  - Zhou,Leilei
AU  - Lou,Rui
AU  - Dong,Shuchen
AU  - Shen,Bo
AU  - Wu,Jianzhong
AU  - Zang,Jialan
AU  - Cao,Haixia
AU  - Shi,Meiqi
AU  - Zhang,Qin
AU  - Feng,Jifeng
TI  - MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment
SN  - 1432-1335
PY  - 2018///0226
KW  - Adenocarcinoma
KW  - diagnosis
KW  - Adenocarcinoma of Lung
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Pharmacological
KW  - metabolism
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Cisplatin
KW  - administration & dosage
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - MicroRNAs
KW  - Oligonucleotide Array Sequence Analysis
KW  - Prognosis
KW  - Transcriptome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s00432-017-2562-8
ER  -